Ignite Creation Date:
2025-12-24 @ 10:22 PM
Ignite Modification Date:
2026-01-02 @ 1:09 PM
Study NCT ID:
NCT06724835
Status:
RECRUITING
Last Update Posted:
2024-12-09
First Post:
2024-12-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Treating Nectin-4-positive Advanced Breast Cancer with XKDCT293 (Nectin-4-CAR-T)
Sponsor:
Shenzhen Celconta Life Science Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-03-11
Start Date Type:
ACTUAL
Primary Completion Date:
2026-03
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-03
Completion Date Type:
ESTIMATED
First Submit Date:
2024-12-05
First Submit QC Date:
None
Study First Post Date:
2024-12-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-05
Last Update Post Date:
2024-12-09
Last Update Post Date Type:
ACTUAL